Loading...
 
 Warning
  • User not in any of the required groups for GroupSelector field

27

Items
Selected Document Category:Published Document
Source:Organization of Economic Cooperation & Development - Working Party on Manufactured Nanomaterials
Anticipated Publication Year:
Publication Year:2012
Acronym:OECD-WPMN
Identifier:ENV/JM/MONO(2012)8
Document Title:Important Issues on Risk Assessment of Manufactured Nanomaterials
url:http://www.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono(2012)8&doclanguage=en
Scope:

This document, Important Issues on Risk Assessment of Manufactured Nanomaterials, provides the current
practices, challenges and strategies for assessing risk in circumstances where data are limited, and there is
a necessity for more research on specific risk assessment issues; however, it is not to be construed to imply
scientific and/or policy endorsement of any specific risk assessment methods or models. It should be noted
that this document is a living document. It was current at the time of 9th meeting of the WPMN (December
2011) and subject to amendment and refinement as research affords further understanding of how to assess
and manage nanomaterials.

Keywords:OECD, WPMN, regulatory, risk assessment
Type of Document:c. Guideline
Issues Areas:Health, Safety, and Environment
Primary Category:Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
Additional CategoriesGeneral Industry/Manufacturing; Food e.g. Preserving/Specialty food manufacturing; Personal care
Goal or Need:

Important Issues on Risk Assessment of Manufactured Nanomaterials, provides the current
practices, challenges and strategies for assessing risk in circumstances where data are limited, and there is a necessity for more research on specific risk assessment issues; however, it is not to be construed to imply scientific and/or policy endorsement of any specific risk assessment methods or models. It should be noted that this document is a living document. It was current at the time of 9th meeting of the WPMN (December
2011) and subject to amendment and refinement as research affords further understanding of how to assess and manage nanomaterials.

Intended Stakeholders:Risk assessors and risk managers are a primary audience. There may be general interest in the nanotechnology community
Is it Being Implemented:
Submitter's Name:Shaun Clancy
Submitter's e-mail:[email protected]
Submitter's Company:Evonik
Additional Comments:
Contact for Additional Info:
Selected Document Category:Published Document
Source:Organization of Economic Cooperation & Development - Working Party on Manufactured Nanomaterials
Anticipated Publication Year:
Publication Year:2012
Acronym:OECD-WPMN
Identifier:ENV/JM/MONO(2012)8
Document Title:Important Issues on Risk Assessment of Manufactured Nanomaterials
url:http://www.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono(2012)8&doclanguage=en
Scope:

This document, Important Issues on Risk Assessment of Manufactured Nanomaterials, provides the current
practices, challenges and strategies for assessing risk in circumstances where data are limited, and there is
a necessity for more research on specific risk assessment issues; however, it is not to be construed to imply
scientific and/or policy endorsement of any specific risk assessment methods or models. It should be noted
that this document is a living document. It was current at the time of 9th meeting of the WPMN (December
2011) and subject to amendment and refinement as research affords further understanding of how to assess
and manage nanomaterials.

Keywords:OECD, WPMN, regulatory, risk assessment
Type of Document:c. Guideline
Issues Areas:Health, Safety, and Environment
Primary Category:Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
Additional CategoriesGeneral Industry/Manufacturing; Food e.g. Preserving/Specialty food manufacturing; Personal care
Goal or Need:

Important Issues on Risk Assessment of Manufactured Nanomaterials, provides the current
practices, challenges and strategies for assessing risk in circumstances where data are limited, and there is a necessity for more research on specific risk assessment issues; however, it is not to be construed to imply scientific and/or policy endorsement of any specific risk assessment methods or models. It should be noted that this document is a living document. It was current at the time of 9th meeting of the WPMN (December
2011) and subject to amendment and refinement as research affords further understanding of how to assess and manage nanomaterials.

Intended Stakeholders:Risk assessors and risk managers are a primary audience. There may be general interest in the nanotechnology community
Is it Being Implemented:
Submitter's Name:Shaun Clancy
Submitter's e-mail:[email protected]
Submitter's Company:Evonik
Additional Comments:
Contact for Additional Info:



::::